SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $14 million versus the consensus estimate of $13.89 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.